Literature DB >> 26631721

Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.

Toshiyuki Takasugi1, Seiji Minegishi1, Akiko Asada1, Taro Saito1, Hiroyuki Kawahara2, Shin-ichi Hisanaga3.   

Abstract

Cdk5 is a versatile protein kinase that is involved in various neuronal activities, such as the migration of newborn neurons, neurite outgrowth, synaptic regulation, and neurodegenerative diseases. Cdk5 requires the p35 regulatory subunit for activation. Because Cdk5 is more abundantly expressed in neurons compared with p35, the p35 protein levels determine the kinase activity of Cdk5. p35 is a protein with a short half-life that is degraded by proteasomes. Although ubiquitination of p35 has been previously reported, the degradation mechanism of p35 is not yet known. Here, we intended to identify the ubiquitination site(s) in p35. Because p35 is myristoylated at the N-terminal glycine, the possible ubiquitination sites are the lysine residues in p35. We mutated all 23 Lys residues to Arg (p35 23R), but p35 23R was still rapidly degraded by proteasomes at a rate similar to wild-type p35. The degradation of p35 23R in primary neurons and the Cdk5 activation ability of p35 23R suggested the occurrence of ubiquitin-independent degradation of p35 in physiological conditions. We found that p35 has the amino acid sequence similar to the ubiquitin-independent degron in the NKX3.1 homeodomain transcription factor. An Ala mutation at Pro-247 in the degron-like sequence made p35 stable. These results suggest that p35 can be degraded by two degradation pathways: ubiquitin-dependent and ubiquitin-independent. The rapid degradation of p35 by two different methods would be a mechanism to suppress the production of p25, which overactivates Cdk5 to induce neuronal cell death.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cyclin-dependent kinase (CDK); cyclin-dependent kinase 5; degron; neuron; proteasome; protein degradation; serine/threonine protein kinase; ubiquitin

Mesh:

Substances:

Year:  2015        PMID: 26631721      PMCID: PMC4813488          DOI: 10.1074/jbc.M115.692871

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.

Authors:  M S Rodriguez; J M Desterro; S Lain; D P Lane; R T Hay
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Neurotoxicity induces cleavage of p35 to p25 by calpain.

Authors:  M S Lee; Y T Kwon; M Li; J Peng; R M Friedlander; L H Tsai
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

Review 3.  Degradation of ornithine decarboxylase by the 26S proteasome.

Authors:  Y Murakami; S Matsufuji; S Hayashi; N Tanahashi; K Tanaka
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

4.  Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25.

Authors:  G Kusakawa; T Saito; R Onuki; K Ishiguro; T Kishimoto; S Hisanaga
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

5.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.

Authors:  G N Patrick; L Zukerberg; M Nikolic; S de la Monte; P Dikkes; L H Tsai
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

Review 6.  Ubiquitin-independent proteasomal degradation.

Authors:  Jenny Erales; Philip Coffino
Journal:  Biochim Biophys Acta       Date:  2013-05-14

7.  Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.

Authors:  Varsha Rao; Bin Guan; Laura N Mutton; Charles J Bieberich
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

Review 8.  Cdk5 activity in the brain - multiple paths of regulation.

Authors:  Kavita Shah; Debomoy K Lahiri
Journal:  J Cell Sci       Date:  2014-06-01       Impact factor: 5.285

9.  Basolateral amygdala bidirectionally modulates stress-induced hippocampal learning and memory deficits through a p25/Cdk5-dependent pathway.

Authors:  Damien Rei; Xenos Mason; Jinsoo Seo; Johannes Gräff; Andrii Rudenko; Jun Wang; Richard Rueda; Sandra Siegert; Sukhee Cho; Rebecca G Canter; Alison E Mungenast; Karl Deisseroth; Li-Huei Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-20       Impact factor: 11.205

Review 10.  Cyclin-dependent kinases.

Authors:  Marcos Malumbres
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

View more
  9 in total

1.  Characterization of the CDK5 gene in Apis cerana cerana (AccCDK5) and a preliminary identification of its activator gene, AccCDK5r1.

Authors:  Guangdong Zhao; Chen Wang; Hongfang Wang; Lijun Gao; Zhenguo Liu; Baohua Xu; Xingqi Guo
Journal:  Cell Stress Chaperones       Date:  2017-07-03       Impact factor: 3.667

2.  Tissue-type plasminogen activator regulates p35-mediated Cdk5 activation in the postsynaptic terminal.

Authors:  Ariel Diaz; Valerie Jeanneret; Paola Merino; Patrick McCann; Manuel Yepes
Journal:  J Cell Sci       Date:  2019-02-28       Impact factor: 5.285

3.  RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation.

Authors:  Dongdong Zhao; Yunqiang Zhou; Yuanhui Huo; Jian Meng; Xiaoxia Xiao; Linkun Han; Xian Zhang; Hong Luo; Dan Can; Hao Sun; Timothy Y Huang; Xin Wang; Jie Zhang; Fa-Rong Liu; Huaxi Xu; Yun-Wu Zhang
Journal:  Cell Death Differ       Date:  2020-09-09       Impact factor: 15.828

4.  Clinical role and biological function of CDK5 in hepatocellular carcinoma: A study based on immunohistochemistry, RNA-seq and in vitro investigation.

Authors:  Rui Zhang; Peng Lin; Hong Yang; Yun He; Yi-Wu Dang; Zhen-Bo Feng; Gang Chen
Journal:  Oncotarget       Date:  2017-11-26

5.  Retrospective assessment of cyclin-dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer.

Authors:  Behnaz Saidy; Emad A Rakha; Andrew R Green; Ian O Ellis; Stewart G Martin; Sarah J Storr
Journal:  J Cell Mol Med       Date:  2020-04-30       Impact factor: 5.310

Review 6.  Post-translational modifications of CDK5 and their biological roles in cancer.

Authors:  Gui-Bin Gao; Yue Sun; Run-Dong Fang; Ying Wang; Yang Wang; Qing-Yu He
Journal:  Mol Biomed       Date:  2021-07-20

7.  Ubiquitin ligase activity inhibits Cdk5 to control axon termination.

Authors:  Muriel Desbois; Karla J Opperman; Jonathan Amezquita; Gabriel Gaglio; Oliver Crawley; Brock Grill
Journal:  PLoS Genet       Date:  2022-04-14       Impact factor: 5.917

Review 8.  Cdk5 links with DNA damage response and cancer.

Authors:  Wan Liu; Jun Li; Yu-Shu Song; Yue Li; Yu-Hong Jia; Hai-Dong Zhao
Journal:  Mol Cancer       Date:  2017-03-14       Impact factor: 27.401

9.  Site-specific phosphorylation of Fbxw7 by Cdk5/p25 and its resulting decreased stability are linked to glutamate-induced excitotoxicity.

Authors:  Yeon Uk Ko; Chiho Kim; Juhyung Lee; Dana Kim; Yoonkyung Kim; Nuri Yun; Young J Oh
Journal:  Cell Death Dis       Date:  2019-08-02       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.